Pharma's Biotech Problem
This article was originally published in Start Up
Executive Summary
Lehman Brothers' Fred Frank suggests that Big Pharma, which needs biotech to create new products, should chip in to support biotech, now in the midst of its greatest ever funding crisis. One of his suggestions: a $500 million VC fund, with the top 20 drug companies being the sole limited partners.